🇺🇸 FDA
Pipeline program

Olaparib, CISPLATIN , Olaparib, KEYTRUDA 25 mg/mL concentrate for solution for infusion, PEMETREXED , CARBOPLATIN

MK-7339-006

Phase 3 small_molecule active

Quick answer

Olaparib, CISPLATIN , Olaparib, KEYTRUDA 25 mg/mL concentrate for solution for infusion, PEMETREXED , CARBOPLATIN for Stage IV lung cancer condition is a Phase 3 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).

Program details

Company
Merck Sharp and Dohme
Indication
Stage IV lung cancer condition
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials